Genetic Analysis AS (NGM:GEAN)

Genetic Analysis AS Statistics

Total Valuation

NGM:GEAN has a market cap or net worth of SEK 57.22 million. The enterprise value is 54.56 million.

Market Cap	57.22M
Enterprise Value	54.56M

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

NGM:GEAN has 69.09 million shares outstanding. The number of shares has increased by 53.63% in one year.

Current Share Class	69.09M
Shares Outstanding	69.09M
Shares Change (YoY)	+53.63%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.59%
Owned by Institutions (%)	11.19%
Float	12.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.01
PB Ratio	3.33
P/TBV Ratio	22.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.22
EV / Sales	2.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.14

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.44.

Current Ratio	1.46
Quick Ratio	1.41
Debt / Equity	0.44
Debt / EBITDA	n/a
Debt / FCF	-1.26
Interest Coverage	-110.48

Financial Efficiency

Return on equity (ROE) is -61.18% and return on invested capital (ROIC) is -29.48%.

Return on Equity (ROE)	-61.18%
Return on Assets (ROA)	-20.46%
Return on Invested Capital (ROIC)	-29.48%
Return on Capital Employed (ROCE)	-52.13%
Revenue Per Employee	1.19M
Profits Per Employee	-808,307
Employee Count	16
Asset Turnover	0.48
Inventory Turnover	3.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.54% in the last 52 weeks. The beta is 2.42, so NGM:GEAN's price volatility has been higher than the market average.

Beta (5Y)	2.42
52-Week Price Change	+0.54%
50-Day Moving Average	1.13
200-Day Moving Average	0.77
Relative Strength Index (RSI)	44.80
Average Volume (20 Days)	56,798

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NGM:GEAN had revenue of SEK 19.01 million and -12.93 million in losses. Loss per share was -0.28.

Revenue	19.01M
Gross Profit	16.20M
Operating Income	-12.86M
Pretax Income	-12.93M
Net Income	-12.93M
EBITDA	-12.59M
EBIT	-12.86M
Loss Per Share	-0.28

Balance Sheet

The company has 10.21 million in cash and 7.50 million in debt, giving a net cash position of 2.70 million or 0.04 per share.

Cash & Cash Equivalents	10.21M
Total Debt	7.50M
Net Cash	2.70M
Net Cash Per Share	0.04
Equity (Book Value)	17.17M
Book Value Per Share	0.35
Working Capital	5.43M

Cash Flow

In the last 12 months, operating cash flow was -5.53 million and capital expenditures -437,013, giving a free cash flow of -5.97 million.

Operating Cash Flow	-5.53M
Capital Expenditures	-437,013
Free Cash Flow	-5.97M
FCF Per Share	-0.09

Margins

Gross margin is 85.22%, with operating and profit margins of -67.65% and -68.02%.

Gross Margin	85.22%
Operating Margin	-67.65%
Pretax Margin	-68.02%
Profit Margin	-68.02%
EBITDA Margin	-66.21%
EBIT Margin	-67.65%
FCF Margin	n/a

Dividends & Yields

NGM:GEAN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-53.63%
Shareholder Yield	n/a
Earnings Yield	-22.60%
FCF Yield	-10.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NGM:GEAN has an Altman Z-Score of -0.19 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.19
Piotroski F-Score	3